Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

163.61
-1.0400-0.63%
Volume:115.14K
Turnover:18.75M
Market Cap:9.79B
PE:-24.20
High:165.73
Open:164.29
Low:161.01
Close:164.65
Loading ...

Ascendis Pharma Q4 Loss Narrows, Revenue Rises -- Shares Up After Hours

MT Newswires Live
·
13 Feb

Stock Track | Ascendis Pharma Soars 5.87% After Beating Q4 Estimates on Strong Sales Growth

Stock Track
·
13 Feb

Ascendis Pharma Q4 2024 GAAP EPS €(0.64) Beats €(1.07) Estimate, Sales €173.916M Beat €111.178M Estimate

Benzinga
·
13 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 Feb

Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald

Dow Jones
·
11 Feb

Ascendis Pharma A/S expected to post a loss of €1.08 a share - Earnings Preview

Reuters
·
11 Feb

Morgan Stanley Remains a Hold on Ascendis Pharma (ASND)

TIPRANKS
·
10 Feb

Ascendis Pharma a/S : Morgan Stanley Raises Target Price to $175 From $167

THOMSON REUTERS
·
04 Feb

Ascendis Pharma A/S expected to post a loss of €1.14 a share - Earnings Preview

Reuters
·
03 Feb

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
01 Feb

Exploring High Growth Tech Stocks In January 2025

Simply Wall St.
·
30 Jan

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
29 Jan

JPMorgan ups Ascendis target, sees buying opportunity on pullback

TIPRANKS
·
29 Jan

J.P. Morgan Sticks to Their Buy Rating for Ascendis Pharma (ASND)

TIPRANKS
·
29 Jan

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?

Insider Monkey
·
23 Jan

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

MT Newswires Live
·
23 Jan